Published in Iran Red Crescent Med J on January 05, 2013
The epidemiology of viral hepatitis in the United States. Gastroenterol Clin North Am (1994) 2.16
Anti-HBc & HBV-DNA detection in blood donors negative for hepatitis B virus surface antigen in reducing risk of transfusion associated HBV infection. Indian J Med Res (2006) 1.79
Intrafamilial prevalence of hepatitis B virus in Western Brazilian Amazon region: epidemiologic and biomolecular study. J Gastroenterol Hepatol (2006) 1.70
Intrafamilial transmission of hepatitis B virus in the eastern Anatolian region of Turkey. Eur J Gastroenterol Hepatol (2003) 1.67
Hepatitis B infection in households of chronic carriers of hepatitis B surface antigen: factors associated with prevalence of infection. Am J Epidemiol (1982) 1.60
Rate of hepatitis B seropositivity following mass vaccination in the Islamic Republic of Iran. East Mediterr Health J (2006) 1.53
Intra-familial prevalence of hepatitis B virologic markers in HBsAg positive family members in Nahavand, Iran. World J Gastroenterol (2005) 1.14
Intrafamilial spread of hepatitis B virus infection in Greece. Eur J Gastroenterol Hepatol (2005) 1.06
Hepatitis B core antigen antibody as an indicator of a low grade carrier state for hepatitis B virus in a Saudi Arabian blood donor population. Transfus Sci (1997) 0.99
Significance of isolated hepatitis B core antibody in blood donors from São Paulo. Rev Inst Med Trop Sao Paulo (2001) 0.97
Hepatitis B infection in Eastern Indian families: need for screening of adult siblings and mothers of adult index cases. Public Health (2005) 0.96
Prevalence of hepatitis A, B, and C markers in school children of a rural area of Crete, Greece. Eur J Epidemiol (1997) 0.95
Screening for hepatitis B virus infection in Egyptian blood donors negative for hepatitis B surface antigen. Hepatol Int (2007) 0.93
Intrafamilial seropositivity of hepatitis in patients with hepatitis B and C virus in hepatitis clinic in Hamadan, Iran. Ann Hepatol (2011) 0.92
Economic evaluation of the societal costs of hepatitis B in South Korea. J Gastroenterol Hepatol (2001) 0.91
Intra-familial spread of hepatitis B virus infection in eastern Turkey. Epidemiol Infect (2007) 0.89
Familial pattern of infection with hepatitis B virus among immigrating Ethiopian Jews in Israel. Eur J Epidemiol (1998) 0.86
Possible transmission of hepatitis B virus between spouses and their children in Babol, Northern Iran. Trop Doct (2007) 0.81
Age related seroprevalence of antibodies to hepatitis A virus in Hyderabad, India. Trop Gastroenterol (2000) 0.79
High prevalence of occult hepatitis B virus infection in children born to HBsAg-positive mothers despite prophylaxis with hepatitis B vaccination and HBIG. J Hepatol (2012) 2.41
Detection of mixed Plasmodium falciparum & P. vivax infections by nested-PCR in Pakistan, Iran & Afghanistan. Indian J Med Res (2010) 1.93
Distribution and risk factors of hepatitis B virus infection in the general population of Central Iran. Hepat Mon (2012) 1.79
Prevalence of hepatitis C virus infection and its related risk factors in drug abuser prisoners in Hamedan--Iran. World J Gastroenterol (2005) 1.67
Spectrum of clinical disease in a series of hospitalized HIV-infected patients from southeast of Iran. Saudi Med J (2006) 1.65
Trends of fatal road traffic injuries in Iran (2004-2011). PLoS One (2013) 1.62
Distribution of hepatitis C virus genotypes in Iranian chronic infected patients. Hepat Mon (2013) 1.59
Family physicians in Iran: success despite challenges. Lancet (2010) 1.57
Evaluation of the efficacy of ribavirin therapy on survival of Crimean-Congo hemorrhagic fever patients: a case-control study. Jpn J Infect Dis (2009) 1.54
Prevalence of hepatitis d virus infection among hepatitis B virus infected patients in qom province, center of iran. Hepat Mon (2012) 1.42
One swallow doesn't bring spring, reply to Khamesipour et al. Transfus Apher Sci (2011) 1.38
Determinants of seeking needed outpatient care in Iran: results from a national health services utilization survey. Arch Iran Med (2007) 1.33
Seroprevalence of Hepatitis Viruses B, C, D and HIV Infection Among Hemodialysis Patients in Kerman Province, South-East Iran. Hepat Mon (2012) 1.27
Hepatitis C in hemodialysis patients: current global magnitude, natural history, diagnostic difficulties, and preventive measures. Am J Nephrol (2008) 1.26
Occult hepatitis C virus infection in Iranian patients with cryptogenic liver disease. J Med Virol (2011) 1.20
Gender differences in healthy ranges for serum alanine aminotransferase levels in adolescence. PLoS One (2011) 1.17
Molecular characterization of Plasmodium vivax clinical isolates in Pakistan and Iran using pvmsp-1, pvmsp-3alpha and pvcsp genes as molecular markers. Parasitol Int (2009) 1.16
Knowledge, attitudes and practice of Iranian medical specialists regarding hepatitis B and C. Hepat Mon (2010) 1.15
Intra-familial prevalence of hepatitis B virologic markers in HBsAg positive family members in Nahavand, Iran. World J Gastroenterol (2005) 1.14
Associates of poor physical and mental health-related quality of life in beta thalassemia-major/intermedia. J Res Med Sci (2009) 1.14
Can we include genetic variants with high linkage disequilibrium into a multiple logistic model? Liver Int (2014) 1.14
Burden of hepatocellular carcinoma in Iran; Bayesian projection and trend analysis. Asian Pac J Cancer Prev (2010) 1.12
Effects of a self-care program on quality of life of cirrhotic patients referring to Tehran Hepatitis Center. Health Qual Life Outcomes (2005) 1.10
Low dose ribavirin for treatment of hepatitis C virus infected thalassemia major patients; new indications for combination therapy. Hepat Mon (2012) 1.10
Transmission of HBV infection from mothers HBsAg positive to infants need to more attention. J Clin Virol (2012) 1.08
Distribution of IL28B Genotypes in Iranian Patients with Chronic Hepatitis C and Healthy Individuals. Hepat Mon (2012) 1.05
Hepatitis B virus infection: need for more attention in hemodialysis patients. Saudi J Kidney Dis Transpl (2013) 1.05
Apoptosis in liver diseases--detection and therapeutic applications. Med Sci Monit (2005) 1.02
Knowledge, attitude, and practice of Iranian surgeons about blood-borne diseases. J Surg Res (2008) 1.02
Development of evidence-based health policy documents in developing countries: a case of Iran. Glob J Health Sci (2014) 1.01
Liver complications in celiac disease. Hepat Mon (2011) 1.01
Real response to therapy in chronic hepatitis C virus patients: a study from iran. Hepat Mon (2012) 0.99
Hepatitis A. Aust Fam Physician (2011) 0.97
IL28B polymorphism, Explanation for Different Responses to Therapy in Hepatitis C Patients. Hepat Mon (2011) 0.96
The impact of Hepatitis C virus infection on kidney transplantation outcomes: A systematic review of 18 observational studies: The impact of HCV on renal transplantation. Hepat Mon (2011) 0.96
Oral fluid and hepatitis A, B and C: a literature review. J Oral Pathol Med (2011) 0.95
Non-alcoholic fatty liver disease and correlation of serum alanin aminotransferase level with histopathologic findings. Hepat Mon (2011) 0.95
A novel method for diagnosing cirrhosis in patients with chronic hepatitis B: artificial neural network approach. J Med Syst (2009) 0.95
Direct medical care costs associated with patients diagnosed with chronic HCV. Hepat Mon (2013) 0.94
Halothane-induced hepatitis: A forgotten issue in developing countries: Halothane-induced hepatitis. Hepat Mon (2011) 0.94
IL28B SNP genotyping among Iranian HCV-infected patients: A preliminary report. Hepat Mon (2011) 0.94
Vaccination against hepatitis B among prisoners in Iran: accelerated vs. classic vaccination. Health Policy (2011) 0.93
Insulin resistance in chronic hepatitis B and C. Indian J Gastroenterol (2007) 0.93
Pretransplant hepatitis C virus infection and its effect on the post-transplant course of living renal allograft recipients. J Gastroenterol Hepatol (2003) 0.93
High prevalence of the 437G mutation associated with sulfadoxine resistance among Plasmodium falciparum clinical isolates from Iran, three years after the introduction of sulfadoxine-pyrimethamine. Int J Infect Dis (2010) 0.92
Influencing Factors on the Outcome and Prognosis of Patients With HBV Infction: Seven Years Follow-up. Hepat Mon (2013) 0.92
Liver Hemangioma Might Lead to overestimation of Liver Fibrosis by Fibroscan; A Missed Issue in Two Cases. Hepat Mon (2012) 0.91
Imaging and Imaging-Guided Interventions in the Diagnosis and Management of Hepatocellular Carcinoma (HCC)-Review of Evidence. Iran J Radiol (2012) 0.91
More risk factors of hepatitis C transmission should be considered in Pakistan. Int J Prev Med (2011) 0.91
Hepatitis C virus infection among patients on hemodialysis: a report from a single center in Iran. Saudi J Kidney Dis Transpl (2009) 0.90
Dietary Quality Indices and Biochemical Parameters Among Patients With Non Alcoholic Fatty Liver Disease (NAFLD). Hepat Mon (2013) 0.90
Risk factors of hepatitis B infection: Health policy makers should be aware of their importance in each community. Hepat Mon (2011) 0.89
Effect of cesarean section on the risk of perinatal transmission of hepatitis C virus from HCV-RNA+/HIV- mothers: a meta-analysis. Arch Gynecol Obstet (2010) 0.89
Prevalence and risk factors of isolated anti-HBc antibody and occult hepatitis B infection in hemodialysis patients: a nationwide study. Ann Hepatol (2013) 0.89
Unthought-of problems regarding hepatitis D virus infection. Hepat Mon (2010) 0.89
Probiotic as a novel treatment strategy against liver disease. Hepat Mon (2013) 0.88
Regulatory T cells are the most important determinant factor of hepatitis B infection prognosis: a systematic review and meta-analysis. Vaccine (2012) 0.88
High prevalence of alpha 1 antitrypsin phenotypes in viral hepatitis B infected patients in Iran. Hepatol Res (2005) 0.88
Hepatitis E virus infection: a general review with a focus on hemodialysis and kidney transplant patients. Am J Nephrol (2010) 0.87
The risk of transmission of Crimean-Congo hemorrhagic fever virus from human cases to first-degree relatives. Jpn J Infect Dis (2008) 0.87
Collecting blood just from voluntary repeated blood donors is the wisdom strategy in Vietnam. Indian J Med Res (2013) 0.86
Estimation of diagnosis and treatment costs of non-alcoholic Fatty liver disease: a two-year observation. Hepat Mon (2013) 0.86
Distribution of hepatitis C virus genotypes among azerbaijani patients in capital city of iran-tehran. Hepat Mon (2013) 0.86
High Rate of Virological Response to Peginterferon α-2a-Ribavirin Among Non-Cirrhotic Iranian Hemophilia Patients With Chronic Hepatitis C. Iran Red Crescent Med J (2012) 0.86
Amazing results with hydroxyurea therapy in chronic hepatitis B: a preliminary report. Hepat Mon (2010) 0.85
Hepatitis C virus as a multifaceted disease: a simple and updated approach for extrahepatic manifestations of hepatitis C virus infection. Hepat Mon (2010) 0.85
Psychometric properties of the Persian version of the World Health Organization's quality of life questionnaire (WHOQOL-100). Arch Iran Med (2011) 0.85
Clinical Features and Seroepidemiology of Anti-HDV Antibody in patients With Chronic Hepatitis B Virus Infection in Iran: A Meta-Analysis. Hepat Mon (2011) 0.85
Efficacy of applying self-assessment of larviciding operation, Chabahar, Iran. Malar J (2012) 0.84
Anxiety and depression affects life and sleep quality in adults with beta-thalassemia. Indian J Hematol Blood Transfus (2009) 0.84
Occult hepatitis C virus infection in candidates for liver transplant with cryptogenic cirrhosis. Hepat Mon (2013) 0.84
Prevalence of hepatitis d in the eastern mediterranean region: systematic review and meta analysis. Hepat Mon (2013) 0.84
Hepatitis B virus surface antigen (HBsAg) mutations are rare but clustered in immune epitopes in chronic carriers from Sistan-Balouchestan Province, Iran. Arch Iran Med (2013) 0.84
Understanding of molecular pain medicine: genetic basis of variation in pain sensation and analgesia response. Anesth Pain Med (2013) 0.83
The road traffic crashes as a neglected public health concern; an observational study from Iranian population. Traffic Inj Prev (2014) 0.83
Intravenous drug use and hepatitis C virus in iran. Hepat Mon (2012) 0.83
Effects of parental education level and economic status on the needs of families of hearing-impaired children in the aural rehabilitation program. Iran J Otorhinolaryngol (2013) 0.82
Hepatitis C and renal transplantation: a review on historical aspects and current issues. Rev Med Virol (2008) 0.82
The effect of education on quality of life in patients under interferon therapy. Hepat Mon (2010) 0.82
Non-alcoholic steatohepatitis and influence of age and gender on histopathologic findings. World J Gastroenterol (2010) 0.82
Association between spasticity and the level of motor function with quality of life in community dwelling Iranian young adults with spastic cerebral palsy. Med J Islam Repub Iran (2012) 0.82
The prevalence of hepatitis B virus surface antigen (HBsAg) variations and correlation with the clinical and serologic pictures in chronic carriers from Khorasan Province, North-East of Iran. Acta Med Iran (2012) 0.82
Hepatic steatosis: prevalence and host/viral risk factors in Iranian patients with chronic hepatitis B infection. Asian Pac J Cancer Prev (2014) 0.82
Patient-to-Patient Transmission of Hepatitis C at Iranian Thalassemia Centers Shown by Genetic Characterization of Viral Strains. Hepat Mon (2013) 0.82
Mutations in the NS5A gene of hepatitis C virus subtype 1b and response to peg-IFNα-2a/RBV combination therapy in Azerbaijani patients. Arch Virol (2014) 0.81
Evolutionary analysis of HBV "S" antigen genetic diversity in Iranian blood donors: a nationwide study. J Med Virol (2013) 0.81
HBV Subgenotypes D1, D2, D-del! Are 'Old' Genotyping Methods Interpreted Correctly? Hepat Mon (2013) 0.81
Geographical mapping and Bayesian spatial modeling of malaria incidence in Sistan and Baluchistan province, Iran. Asian Pac J Trop Med (2011) 0.81
Prevalence of hepatitis delta virus (HDV) infection in chronic hepatitis B patients with unusual clinical pictures. Hepat Mon (2013) 0.81
Plasma zinc level in hepatitis C patients with or without Beta thalassemia major; is there any difference? Hepat Mon (2013) 0.81
Associations between human TRIM22 gene expression and the response to combination therapy with Peg-IFNα-2a and ribavirin in Iranian patients with chronic hepatitis C. J Med Virol (2014) 0.81
Occult hepatitis B and hemodialysis patients need increased precautions with the interpretation of results. Ther Apher Dial (2010) 0.81
Main determinants of catastrophic health expenditures: a Bayesian logit approach on Iranian household survey data (2010). Glob J Health Sci (2015) 0.81
Prevalence of occult hepatitis B virus in plasma and peripheral blood mononuclear cell compartments of patients with chronic hepatitis C infection in tehran-iran. Hepat Mon (2013) 0.80
Successful exclusion of blood-borne viral disease in blood donors. Eur J Intern Med (2011) 0.80
Application of zero-inflated poisson mixed models in prognostic factors of hepatitis C. Biomed Res Int (2013) 0.80
Risk factors of viral hepatitis: yet to explore. Transfus Apher Sci (2012) 0.80
Mutational analysis of HBs Ag-positive mothers and their infected children despite immunoprophylaxis. Iran J Allergy Asthma Immunol (2013) 0.80